Zurück zu Ihrem Suchergebnis

Beschreibung

A potent, cell-premeable, reversible, substrate competitive, and selective inhibitor of HER-2 (neu/erbB-2, IC50 = 0.35 µ,M) relative to HER-1 (IC50 = 19 µ,M) autophosphorylation. The inhibition is competitive with respect to ATP binding. Enhances the chemosensitivity in non-small cell lung cancer (NSCLC) cell lines expressing high levels of p185neu., A potent, cell-premeable, reversible, substrate competitive, and selective inhibitor of HER2 (neu/ErbB2, IC50 = 0.35 µ,M) relative to HER1 (IC50 = 19 µ,M) autophosphorylation. The inhibition is competitive with respect to ATP binding. Enhances chemosensitivity in non-small cell lung cancer (NSCLC) cell lines expressing high levels of p185neu.